Association Between Advanced Fibrosis and Epigenetic Age Acceleration among Individuals with MASLD.

Haili Wang,Zhenqiu Liu,Hong Fan,Chengnan Guo,Xin Zhang,Yi Li,Suzhen Zhao,Luojia Dai,Ming Zhao,Tiejun Zhang
DOI: https://doi.org/10.1007/s00535-024-02181-0
2024-01-01
Journal of Gastroenterology
Abstract:The biological process of aging plays an important role in the progress of liver fibrosis. However, epidemiological evidence about the associations between advanced fibrosis and epigenetic age acceleration (EAA) among individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) is limited. We utilized publicly available DNA methylation data (GSE180474) for our analysis. Five EAA measures were calculated in this study, including IEAA, PhenoAA, GrimAA, DunedinPACE, and DNAmTLAA. Separate linear regression models were conducted to explore the associations between different fibrosis grades and each measure of EAA. A total of 325 participants were included in this study, with a mean (± SD) age of 48.56 ± 11.50 years. Of these participants, 64.6
What problem does this paper attempt to address?